Optimized Synthesis and Pharmacological Evaluation of HCN Channel Inhibitor EC18

April 4, 2023

Title

Optimized Synthesis and Pharmacological Evaluation of HCN Channel Inhibitor EC18

Author

Patberg, Marius, Tengiz Oniani, Paul Disse, Stefan Peischard, Laura Vinnenberg, Mehrnoush Zobeiri, Maria N. Romanelli, Lisa Epping, Heinz Wiendl, Sven G. Meuth, Petra Hundehege, Guiscard Seebohm, Thomas Budde, and Anna Junker

Year

2023

Journal

Archiv Der Pharmazie

Abstract

HCN4 channels are considered to be a promising target for cardiac pathologies, epilepsy, and multiple sclerosis. However, there are no subtype-selective HCN channel blockers available, and only a few compounds are reported to display subtype preferences, one of which is EC18 (cis-1). Herein, we report the optimized synthetic route for the preparation of EC18 and its evaluation in three different pharmacological models, allowing us to assess its activity on cardiac function, thalamocortical neurons, and immune cells.

Instrument

unknown

Keywords

HCN channel,ion channels